BHF Kleinwort Benson Group’s Celgene Corp CELG Stock Holding History

BHF Kleinwort Benson Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-78,609	Closed	-$9.41M	–	476
2015 Q4	$9.41M	Buy	+78,609	New	+$9.09M	0.22%	116
2015 Q3	–	Sell	-94,384	Closed	-$10.9M	–	557
2015 Q2	$10.9M	Sell	94,384 -6,505	-6%	-$744K	0.37%	78
2015 Q1	$11.6M	Sell	100,889 -10,270	-9%	-$1.23M	0.32%	92
2014 Q4	$12.4M	Buy	111,159 +6,275	+6%	+$662K	0.32%	102
2014 Q3	$9.94M	Buy	104,884 +50,682	+94%	+$4.57M	0.32%	87
2014 Q2	$4.66M	Sell	54,202 -91,132	-63%	-$6.93M	0.14%	145
2014 Q1	$10.1M	Buy	145,334 +66,054	+83%	+$5.23M	0.29%	96
2013 Q4	$6.7M	Buy	+79,280	New	+$6.27M	0.43%	86

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BHF Kleinwort Benson Group's CELG Position: Q1 2016 in Review

BHF Kleinwort Benson Group sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 78,609 shares — an estimated $9.41M sold.

BHF Kleinwort Benson Group first reported a position in CELG in Q4 2013 and held it in 8 quarters. The position peaked at $12.4M in Q4 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

BHF Kleinwort Benson Group reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
BHF Kleinwort Benson Group sold 78,609 Celgene Corp shares in Q1 2016, an estimated $9.41M.
BHF Kleinwort Benson Group first reported a position in Celgene Corp in Q4 2013 and held it in 8 quarters.
BHF Kleinwort Benson Group's Celgene Corp position peaked at $12.4M in Q4 2014.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.